[1]
|
WHO, “Antiretroviral Therapy for HIV Infection in Adults and Adolescents,” Recommendations for a Public Health Approach, WHO, 2006, p. 26.
|
[2]
|
V. Levy and M. Robert, “Antiretroviral Therapy for Hepatitis B Virus-HIV Co-Infected Patients: Promises and Pitfalls,” Clinical Infectious Diseases, Vol. 43, No. 10, 2006, pp. 904-910. http://dx.doi.org/10.1086/507532
|
[3]
|
H. L. Omland, et al., “Impact of Hepatitis B Virus CoInfection on Response to Highly Active Antiretroviral Treatment and Outcome in HIV-Infected Individuals: A Nationwide Cohort Study,” British HIV Association HIV Medicine, Vol. 9, No. 5, 2008, pp. 300-306. http://dx.doi.org/10.1111/j.1468-1293.2008.00564.x
|
[4]
|
K. Lacombe, et al., “HIV/Hepatitis B Virus Co-Infection: Current Challenges and New Strategies,” Journal of Antimicrobial Chemotherapy, Vol. 65, No. 1, 2010, pp. 10-17. http://dx.doi.org/10.1093/jac/dkp414
|
[5]
|
S. Kenneth, P. Marion and K. Margaret, “HIV and Liver Disease Forum: Conference Proceedings,” Hepatology, Vol. 45, No. 6, 2007, pp. 1566-1577. http://dx.doi.org/10.1002/hep.21722
|
[6]
|
C. J. Hoffmann and C. L. Thio, “Clinical Implications of HIV and Hepatitis B Co-Infection in Asia and Africa,” The Lancet Infectious Diseases, Vol. 7, No. 6, 2007, pp. 402-409. http://dx.doi.org/10.1016/S1473-3099(07)70135-4
|
[7]
|
M. G. Peters, “Diagnosis and Management of Hepatitis B Virus and HIV Coinfection,” Topics in HIV Medicine, Vol. 15, No. 5, 2007, pp. 163-166.
|
[8]
|
M. Gomez-Gonzalo, M. Carretero and J. Rullas, “The Hepatitis B Virus X Protein Induces HIV-1 Replication and Transcription in Synergy with T-Cell Activation Signals,” The Journal of Biological Chemistry, Vol. 38, 1976, pp. 35435-35443.
|
[9]
|
V. Soriano, et al., “Care of HIV Patients with Chronic Hepatitis B: Updated Recommendations from the HIVHepatitis B Virus International Panel,” AIDS, Vol. 22, No. 12, 2008, pp. 1399-1410. http://dx.doi.org/10.1097/QAD.0b013e3282f8b46f
|
[10]
|
V. DiMartino, “Influence of HIV Infection on the Response to Interferon Therapy and the Long Term Outcome of Chronic Hepatitis B,” Gastroenterology, Vol. 123, No. 6, 2002, pp. 1812-1822. http://dx.doi.org/10.1053/gast.2002.37061
|
[11]
|
E. Ameeta and T. Wong, “HIV and Hepatitis B Co-Infection: Background Document,” WHO, 2009.
|
[12]
|
R. K. Sterling, “Hepatitis B Virus in the Setting of HIV Infection: A Clinical Challenge. Medical Writers’ Circle,” 2003. http://www.hcvadvocate.org/hcsp/board.asp
|
[13]
|
A. DeLuca, R. Bugarini and A. C. Lepri, “Co-Infection with Hepatitis Viruses and Outcome of Initial Antiretroviral Regimens in Previously Naive HIV-Infected Subjects,” Archives of Internal Medicine, Vol. 162, No. 18, 2002, pp. 2125-2132. http://dx.doi.org/10.1001/archinte.162.18.2125
|
[14]
|
J. Idoko, S. Meloni and M. Muazu, “Hepatitis B virus CoInfection Impacts Baseline HIV Parameters and HAARTRelated Hepatotoxicity Risk in an HIV-Infected Nigerian Cohort,” 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, 25-28 February 2007.
|
[15]
|
M. Puoti, et al., “Hepatitis B Virus Co-Infection in Human Immunodeficiency Virus-Infected Subjects,” AIDS Reviews, Vol. 4, No. 1, 2002, pp. 27-35.
|
[16]
|
C. L. Thio, et al., “HIV-1, Hepatitis B Virus, and Risk of Liver Related Mortality in the Multicenter Cohort Study (MACS),” Lancet, Vol. 360, No. 9349, 2002, pp. 1921-1926. http://dx.doi.org/10.1016/S0140-6736(02)11913-1
|
[17]
|
T. Wilkin, “What Causes Poor CD4-Cell Recovery in the Setting of Suppressive Antiretroviral Therapy?” Journal Watch HIV/AIDS Clinical Care, 2010. http://aids-clinical-care.jwatch.org
|
[18]
|
J. J. Chang, et al., “Reduced Hepatitis B Virus (HBV)Specific CD4_ T-Cell Responses in Human Immunodeficiency Virus Type 1-HBV-Coinfected Individuals Receiving HBV-Active Antiretroviral Therapy,” Journal of Virology, Vol. 79, No. 5, 2005, pp. 3038-3051. http://dx.doi.org/10.1128/JVI.79.5.3038-3051.2005
|
[19]
|
M. Crane, S. Sirivichayakul and J. J. Chang, “No Increase in Hepatitis B Virus (HBV)-Specific CD8-T Cells in Patients with HIV-1-HBV Co-Infections Following HBVActive HAART,” Journal of Virology, Vol. 84, No. 6, 2010, pp. 2657-2665. http://dx.doi.org/10.1128/JVI.02124-09
|
[20]
|
M. Mascolini, “Older Age, Lower CD4 Nadir, NNRTI Use Predict Slow CD4 Recovery in Athena,” 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, 16-19 February 2010.
|
[21]
|
S. Mauss, et al., “Hepatology: A Clinical Textbook,” Flying Publisher, Germany, 2009. www.HepatologyTextbook.com
|
[22]
|
Y. Benhamou, M. Bochet and V. Thibault, “Long-Term Incidence of Hepatitis B Virus Resistance to Lamivudine in Human Immunodeficiency Virus-Infected Patients,” Hepatology, Vol. 30, No. 5, 1999, pp. 1302-1306. http://dx.doi.org/10.1002/hep.510300525
|